Left Atrial Appendage (LAA) Closure Devices Market Business Growth StatisticsPosted by sunny on May 20th, 2019 This sac controls the electrical impulses during atrial fibrillation. The LAA closure devices are the interventional devices that is used to prevent stroke and emboli caused due to atrial fibrillation. Factors such as increase in number of product approvals of atrial intervention, rise in incidences of atrial fibrillation and heart stroke cases, rise in aging population, disorders due to hypertension, and disturbed lifestyle habits such as smoking drive the market growth. However, stringent regulations by government and high acceptance of alternatives drugs such as warfarin and dabigatran restrain the market growth. Moreover, increase in awareness programs in untapped market provide numerous opportunities for the market growth in the forecast period. Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4132 The left atrial appendage closure devices market is segmented on the basis of product, end user, and geography. On the basis of product, it is bifurcated into epicardial LAA closure devices and endocardial LAA closure devices. On the basis of end user, it is divided into heart clinics, hospitals, and ambulatory service centers. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). The key players operating in the market include AtriCure, Inc., Boston Scientific Corporation, Coherex Medical, St. Jude Medical, Occlutech, Lifetech Scientific, SentreHEART, Inc., Avantis Medical Systems, United-Guardian, Inc., and Carestream Health. Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4132
Key Benefits
Like it? Share it!More by this author |